|
REXO2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.523330E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.738920E-03 |
| Normal-vs-Stage2 |
3.446600E-01 |
| Normal-vs-Stage3 |
3.839900E-03 |
| Normal-vs-Stage4 |
8.060200E-02 |
| Stage1-vs-Stage2 |
6.604400E-03 |
| Stage1-vs-Stage3 |
4.243000E-01 |
| Stage1-vs-Stage4 |
9.695000E-01 |
| Stage2-vs-Stage3 |
6.580300E-03 |
| Stage2-vs-Stage4 |
3.698500E-02 |
| Stage3-vs-Stage4 |
6.353600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.596600E-04 |
| Normal-vs-AfricanAmerican |
5.721400E-01 |
| Normal-vs-Asian |
6.119100E-03 |
| Caucasian-vs-AfricanAmerican |
3.409600E-01 |
| Caucasian-vs-Asian |
5.326400E-01 |
| AfricanAmerican-vs-Asian |
1.513400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.673500E-02 |
| Normal-vs-Female |
1.420610E-03 |
| Male-vs-Female |
6.149800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.434700E-04 |
| Normal-vs-Age(41-60Yrs) |
1.690080E-02 |
| Normal-vs-Age(61-80Yrs) |
7.477000E-01 |
| Normal-vs-Age(81-100Yrs) |
3.030000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.999640E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.802400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.247400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.441610E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.015600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.434200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.797750E-02 |
| Classical-VS-Follicular |
1.1403100685925E-12 |
| Classical-VS-Other |
3.457600E-01 |
| Classical-VS-Normal |
1.0757999999722E-06 |
| Tall-VS-Follicular |
1.16239995406886E-09 |
| Tall-VS-Other |
1.031950E-01 |
| Tall-VS-Normal |
1.389070E-04 |
| Follicular-VS-Other |
3.738800E-01 |
| Follicular-VS-Normal |
5.804000E-04 |
| Other-VS-Normal |
8.724200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.473400E-01 |
| Normal-vs-N1 |
1.498350E-02 |
| N0-vs-N1 |
2.733600E-02 |
|
|
